Minerva Neurosciences Announces 2026 Annual Meeting Date and Stockholder Proposal Deadlines

Minerva Neurosciences, Inc. filed a Form 8-K on April 6, 2026, to announce the scheduling of its 2026 Annual Meeting of Stockholders. The meeting is expected to be held on June 3, 2026. Because this date is more than 30 days before the one-year anniversary of the previous year's annual meeting, the company has established new deadlines for stockholder proposals and director nominations. To be considered for inclusion in the company's proxy statement pursuant to Rule 14a-8, stockholder proposals must be received at the company's principal executive offices by the close of business on April 16, 2026. For any other business or director nominations to be brought before the Annual Meeting, stockholders must provide notice no later than the close of business on April 21, 2026. All submissions must comply with the company's Bylaws and applicable SEC regulations. The filing was signed by Frederick Ahlholm, Chief Financial Officer.